An increased releasing of this protein to the blood of PD patients was explained discovering that in a large cohort of clinical samples (267 PD and 215 controls); the levels of plasma exosomal α-synuclein were significantly higher in PD patients. The gene discussed is SNCA; the disease is Parkinson disease.